Literature DB >> 6679327

Effect of ionizing radiation on synthesis of sub-replicon size DNA in ataxia telangiectasia cells.

J Houldsworth, M F Lavin.   

Abstract

The effect of gamma-radiation on the synthesis of short fragments of DNA was studied in control and ataxia telangiectasia lymphoblastoid cell lines. Cells were pulsed with [3H]thymidine for 90 sec, which resulted in labelling of DNA fragments ranging from 0.1-2.1 x 10(7) daltons in size in both control and ataxia telangiectasia cells. After exposure to 800 rad of gamma-rays, a decrease in the formation of DNA over this molecular weight range was observed in four control cell lines, 30 min post-irradiation. Four ataxia telangiectasia cell lines however exhibited no reduction in the synthesis of sub-replicon size DNA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6679327

Source DB:  PubMed          Journal:  Biochem Int        ISSN: 0158-5231


  4 in total

1.  Autophosphorylation and ATM activation: additional sites add to the complexity.

Authors:  Sergei V Kozlov; Mark E Graham; Burkhard Jakob; Frank Tobias; Amanda W Kijas; Marcel Tanuji; Philip Chen; Phillip J Robinson; Gisela Taucher-Scholz; Keiji Suzuki; Sairai So; David Chen; Martin F Lavin
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

2.  Comprehensive profiling of radiosensitive human cell lines with DNA damage response assays identifies the neutral comet assay as a potential surrogate for clonogenic survival.

Authors:  Shareef A Nahas; Robert Davies; Francesca Fike; Kotoka Nakamura; Liutao Du; Refik Kayali; Nathan T Martin; Patrick Concannon; Richard A Gatti
Journal:  Radiat Res       Date:  2011-09-30       Impact factor: 2.841

3.  Regulation of DNA replication by the S-phase DNA damage checkpoint.

Authors:  Nicholas Willis; Nicholas Rhind
Journal:  Cell Div       Date:  2009-07-03       Impact factor: 5.130

Review 4.  Chemotherapy induced DNA damage response: convergence of drugs and pathways.

Authors:  Derek Woods; John J Turchi
Journal:  Cancer Biol Ther       Date:  2013-02-04       Impact factor: 4.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.